2-Bromo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine>98.0%(GC)(T)1g

7-CHLOROQUINOLINE-4-CARBOXYLIC ACID, 97.0%, 5g

4-chloro-N-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 500mg

Indium(III) iodide, ROTI®METIC 99.999% (5N), 1 g, HDPE

3-Fluoro-4-nitrobenzoic acid, 98.0%, 25g

3-Oxo-3,4-dihydro-2H-1,4-benzoxazine-6-carboxylic acid, 97.0%, 1g

Flat flange reaction vial DURAN®, DN 150, 6000 ml, 184 mm, 215 mm, Height, 320 mm, 1 Piece

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-{[(propan-2-yl)[(1r,3s)-3-[2-(6-tert-butyl-1H-1,3-benzodiazol-2-yl)ethyl]cyclobutyl]amino]methyl}oxolane-3,4-diol, 99.99%, 100mg

Tert-butyl 4-(4-chlorobenzyl)-4-cyanopiperidine-1-carboxylate, 98%, 250mg

Round filters Type, MN 640 w, , 55 mm, 100 Piece(s)

4-(Ethoxycarbonyl)-3-fluorophenylboronic Acid (contains varying amounts of Anhydride)5g

(6-Carbamoylpyridin-3-yl)boronic acid, 97%, 250mg

methyl 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate, 95%, 1g